Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Current Deferred Tax Assets (2016)

Cryo Cell International's Current Deferred Tax Assets history spans 5 years, with the latest figure at $2.2 million for Q3 2016.

  • Quarterly results put Current Deferred Tax Assets at $2.2 million for Q3 2016, up 62.58% from a year ago — trailing twelve months through Aug 2016 was $2.2 million (up 62.58% YoY), and the annual figure for FY2015 was $1.3 million, changed.
  • Current Deferred Tax Assets for Q3 2016 was $2.2 million at Cryo Cell International, up from $1.3 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $2.2 million in Q3 2016 to a low of $209919.0 in Q1 2012.
  • The 3-year median for Current Deferred Tax Assets is $1.3 million (2015), against an average of $1.3 million.
  • Peak annual rise in Current Deferred Tax Assets hit 62.58% in 2016, while the deepest fall reached 62.58% in 2016.
  • Year by year, Current Deferred Tax Assets stood at $209919.0 in 2012, then surged by 536.44% to $1.3 million in 2015, then soared by 63.02% to $2.2 million in 2016.
  • According to Business Quant data, Current Deferred Tax Assets over the past three periods came in at $2.2 million, $1.3 million, and $1.3 million for Q3 2016, Q2 2016, and Q1 2016 respectively.